Prevalence of Clostridium difficile-associated diarrhoea among hospitalized Jordanian patients
AbstractWe investigated stool specimens of 400 patients at Jordan University Hospital [300 patients with clinical diarrhoea and 100 controls without diarrhoea] for the presence of Clostridium difficile or its toxin. We found a 9.7% prevalence rate of C. difficile or its toxin in stools of patients with diarrhoea. The prevalence of other potential enteric pathogens, such as Salmonella spp. [2.3%], Shigella spp. [1.0%] and Entamoeba histolytica [2.7%], was significantly less. Prevalence of C. difficile or its toxin in controls was 3.0%. Toxin A was detected in 93.1% of C. difficile-associated diarrhoea cases using an enzyme immunoassay. Our study indicates that C. difficile-associated diarrhoea is mostly observed among hospitalized patients aged > or = 50 years, in association with antimicrobial treatment
Shehabi, A.A., Abu Ragheb, H.A. & Allaham, N.A. (2001). Prevalence of Clostridium difficile-associated diarrhoea among hospitalized Jordanian patients. EMHJ - Eastern Mediterranean Health Journal, 7 (4-5), 750-755, 2001 http://www.who.int/iris/handle/10665/119083
JournalEMHJ - Eastern Mediterranean Health Journal, 7 (4-5), 750-755, 2001
MetadataShow full item record
Showing items related by title and MeSH subject.
Why were molecular studies not considered to classify Clostridium difficile isolates implicated in an outbreak? Wong-McClure, Roy A.; Abarca-Gómez, Leandra; Badilla-Vargas, Xiomara; Guevara-Rodríguez, Moraima; Solano-Chinchilla, Antonio; Marchena-Picado, Margarita; O'Shea, Michele (2013)
Why were molecular studies not considered to classify Clostridium difficile isolates implicated in an outbreak? Rodríguez-Cavallini, Evelyn; Gamboa Coronado, María del Mar; Sánchez, César Rodríguez; Quesada Gómez, Carlos (2013)